Aytu BioPharma, Inc.
Hedge Funds Holdings
Last updated:
Aytu BioPharma, Inc.‘s stocks are currently a part of 26 hedge funds’ portfolios, which represents 12.19% of the total amount of its stocks outstanding. This makes up a total of 3.61M shares of Aytu BioPharma, Inc.. Compared to the previous quarter, the number fell by -35.14% or -1.96M shares fewer. As for the holding position changes, 23.08% (6) of current hedge fund investors increased the number of shares held, 30.77% (8) of current holders sold a part of the shares held, and 23.08% (6) closed the holdings completely. 6 hedge funds are new holders of Aytu BioPharma, Inc. stock in Q2 2022, it is 23.08% of total holders.
Hedge funds holding Aytu BioPharma (Q1 2017 – Q2 2022)
| Q1 2017 | 0 |
|---|---|
| Q4 2017 | 4 |
| Q1 2018 | 10 |
| Q2 2018 | 14 |
| Q3 2018 | 7 |
| Q4 2018 | 11 |
| Q1 2019 | 9 |
| Q2 2019 | 13 |
| Q3 2019 | 11 |
| Q4 2019 | 8 |
| Q1 2020 | 30 |
| Q2 2020 | 63 |
| Q3 2020 | 55 |
| Q4 2020 | 38 |
| Q1 2021 | 58 |
| Q2 2021 | 47 |
| Q3 2021 | 36 |
| Q4 2021 | 34 |
| Q1 2022 | 27 |
| Q2 2022 | 26 |
Hedge funds changes in Aytu BioPharma positions (Q1 2017 – Q2 2022)
| Q1 2017 | 0 | 0 | 0 | 1 | -1 |
|---|---|---|---|---|---|
| Q4 2017 | 4 | 0 | 0 | 0 | 0 |
| Q1 2018 | 8 | 2 | 0 | 2 | -2 |
| Q2 2018 | 7 | 4 | 1 | 3 | -1 |
| Q3 2018 | 7 | 0 | 0 | 14 | -14 |
| Q4 2018 | 7 | 3 | 0 | 3 | -2 |
| Q1 2019 | 4 | 2 | 0 | 6 | -3 |
| Q2 2019 | 6 | 3 | 1 | 2 | 1 |
| Q3 2019 | 4 | 2 | 2 | 6 | -3 |
| Q4 2019 | 2 | 3 | 0 | 5 | -2 |
| Q1 2020 | 23 | 4 | 2 | 1 | 0 |
| Q2 2020 | 40 | 15 | 6 | 7 | -5 |
| Q3 2020 | 6 | 21 | 18 | 14 | -4 |
| Q4 2020 | 38 | 0 | 0 | 54 | -54 |
| Q1 2021 | 25 | 22 | 6 | 5 | 0 |
| Q2 2021 | 11 | 14 | 15 | 22 | -15 |
| Q3 2021 | 2 | 17 | 10 | 13 | -6 |
| Q4 2021 | 5 | 9 | 14 | 7 | -1 |
| Q1 2022 | 2 | 8 | 11 | 9 | -3 |
| Q2 2022 | 6 | 6 | 8 | 6 | 0 |
Hedge funds changes in Aytu BioPharma stock options (Q1 2017 – Q2 2022)
| Q1 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 368,000 | 152,000 |
| Q2 2021 | 1,374,000 | 808,000 |
| Q3 2021 | 194,000 | 261,000 |
| Q4 2021 | 3,000,000,242,000 | 24,000 |
| Q1 2022 | 177,000 | 0 |
| Q2 2022 | 149,000 | 0 |